Captario provides an enterprise platform for Strategic Portfolio Management in pharma, uniting Commercial, R&D, and Finance to enable real-time scenario planning and faster, defensible portfolio decisions. It enables revenue-gap analysis, hypothetical asset injections, launch/revenue probability assessment, and comparison of program options across time, cost, value, and risk, delivering decision-ready insights in seconds and revealing interdependencies and resource bottlenecks. The platform is trusted by nine of the top 50 global pharma companies and powers portfolio decisions worth over $30 billion across R&D, business development, and commercial operations, including de-risking M&A and strategic investments.
AI named Captario in August 2026.
Brand page for captario